Welcome Guest (Jacksonville, FL )
Change Name or City
Dental Professionals Click Here!
Inside Magazine      Ask Dear Doctor      Smile Makeover Contest      Smile Poll      Subscribe      Dental Plan      Press      Contact Us
          Home   >   Inside The Magazine   >   Issue 3   >   Blood Pressure Medications


Blood Pressure Medications

Side effects of blood pressure medications include gum overgrowth and dry mouth
A Consultation with Dr. Andrew Rosenblatt

Dear Doctor,
Is it true that some blood pressure medication can cause gum overgrowth?


Dear Charles (Connecticut),
es, it is true - an important class of drugs known as "calcium channel blockers" (CCBs), used for treating high blood pressure, angina and abnormal heart rhythms can cause gingival (gum) hyperplasia (overgrowth), a condition where the gum tissues grow and extend abnormally over part of the teeth. Gum overgrowth can cause pain and discomfort, as well as social embarrassment.

CCBs, which may also be used by cardiac (heart) patients who can't tolerate beta-blockers (other blood pressure drugs), work by dilating (relaxing) blood vessels, which makes it easier for the heart to pump and reduce its workload. They have their share of medical side effects, including constipation, nausea, headache, rash, edema (swelling of the legs with fluid), low blood pressure, drowsiness and dizziness. For the dental patient, in addition to gingival hyperplasia, CCBs can also cause mouth dryness.

Research of late has found that there is a contributing factor along with CCBs in the development of gum overgrowth: poor oral hygiene. Accumulated dental bacterial plaque is the primary cause of periodontal (gum) disease, which increases the likelihood of gum overgrowth; in like fashion, the presence of gum overgrowth makes adequate oral hygiene more difficult, increasing the risk for greater instances of periodontal disease.

A study by Dr. Robert Genco, released in 1999 in the Journal of Periodontology, suggests that frequent dental visits following initial periodontal treatment may significantly reduce gum overgrowth in patients taking Nifedipine, a commonly prescribed CCB. The study found that gingival overgrowth recurrence was eliminated in more than half of patients with a combination of initial periodontal therapy, including both non-surgical and surgical treatments, and frequent follow-up dental visits (this is a significant advancement over earlier research, which concluded that gingival overgrowth could be minimized but not prevented with periodontal therapy and frequent dental visits).

For the roughly twenty to forty percent of Nifedipine patients who also suffer from gum overgrowth, the findings give some hope that they can continue to take the drug and control the gum overgrowth through meticulous attention to correct dental hygiene. It's especially important for patients who don't have the option of switching medications to control their high blood pressure.

If you are taking CCBs for high blood pressure and notice gum overgrowth, your dentist can give you detailed hygiene instructions, and may ask you to visit more often for professional cleanings. If you stop taking the drugs, your gums recede somewhat; however, this may take several months and they may not return to normal on their own. Additional treatment may be needed.

And, it's always a good idea to make sure your dentist knows which drugs you are taking for your high blood pressure and other conditions that may cause dental side effects.

Sincerely,
Andrew Rosenblatt, MD
Andrew Rosenblatt, MD
Dr. Andrew Rosenblatt, MD, is Program Director of the Cardiology Fellowship Training Program at California Pacific, and Director of the Echocardiography Laboratory. He attended NYU, graduating with a degree in Classics, and Albert Einstein College of Medicine. After serving his internship, residency, and chief residency at Jacobi Medical Center-Albert Einstein, in New York City, he did his Cardiology Fellowship at Pacific Presbyterian Medical Center. Dr. Rosenblatt practices cardiology with an emphasis on consultative, non-invasive, and adult congenital cardiology. In addition to directing the cardiology fellowship at CPMC, he is a Clinical Professor of Medicine at UCSF and is a volunteer physician for the San Francisco Opera.



Other Consultations of Interest
Implant Success Rate
Factors which influence one of dentistry's most successful treatments Read
Fosamax® and Surgery
Is there a risk to taking Fosamax® and other bisphosphonates when preparing for surgery? Read

Email your dental questions to consultations@deardoctor.com. Look for the answer in an upcoming issue!

Inside the Magazine  |  Ask a Question  |  Smile Makeover Contest  |  Smile Poll |  Subscribe |  Dental Plan  |  Find A Dentist  |  Contact Us
Are you a Dental Professional?  |  866-429-8188 (toll-free)  |  info@deardoctor.com  |  National Advertising  |  Dentistry  |  Latest News & Press
Copyright © 2010 Dear Doctor, Inc. All rights reserved.  Terms of Use  |  Privacy Policy

DearDoctor.com is the home of Dear Doctor - Dentistry & Oral Health, a quarterly publication written exclusively
by dental health care professionals for the education and well-being of you, the general public.
We will provide you with information that is accurate, authoritative, and trustworthy on all aspects of dentistry.

Disclaimer - This website does not engage in any medical services nor does it provide medical advice.
Dear Doctor, its employees and its Editorial Advisory Board do not endorse any of the procedures or technologies presented on this site.
No action should be taken based upon the contents of this website; instead please consult with your dental professional.